Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects



Status:Active, not recruiting
Conditions:Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:Any
Updated:4/21/2016
Start Date:December 2014
End Date:June 2016

Use our guide to learn which trials are right for you!

Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)

This clinical performance study is being conducted to evaluate the performance of the Aptima
Herpes Simplex Viruses 1 & 2 assay for detection of herpes simplex virus (HSV) type 1
(HSV-1) and HSV type 2 (HSV-2) in swab samples prospectively collected from suspected HSV
lesions in the male anogenital region, the female anogenital region, the oral cavity and
other mucomembranous or mucocutaneous areas of the face (oral/facial), and the skin.
Specimens collected using swabs from viral transport medium (VTM)collection kits and Aptima
swab collection kits will be evaluated.


Inclusion Criteria:

- The subject has at least 1 active lesion (lesion with exudates and cellular material;
eg, vesicle, ulcer) that is suspected to be caused by HSV (as determined by the
clinician)

- The subject and/or legally authorized representative is willing and able to provide
consent prior to study participation (a minor will need the documented consent of
his/her parent or legal guardian, unless the site has an institutional review
board-approved waiver for parental consent for minors)

Exclusion Criteria:

- The subject has only HSV lesions without exudates and cellular material

- The subject used a topical or oral antiviral medication used to treat HSV within 21
days of enrollment

- Subject already participated in this study

- Subject has a history of illness that the principal investigator (PI) or designee
considers could interfere with or affect the conduct, results, and/or completion of
the study

- Subject has a history of illness that the PI or designee considers could create an
unacceptable risk to the subject if enrolled in the study
We found this trial at
22
sites
Houston, Texas 77023
Principal Investigator: Paul Fine, MD
Phone: 713-831-6553
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
1720 2nd Ave S
Birmingham, Alabama 35233
(205) 934-4011 
Principal Investigator: Jane Schwebke, MD
Phone: 205-975-5665
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
1920
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Boise, Idaho
Principal Investigator: Mark Turner, MD
Phone: 208-377-8653
666
mi
from 91732
Boise, ID
Click here to add this to my saved trials
Burlington, North Carolina 27215
2171
mi
from 91732
Burlington, NC
Click here to add this to my saved trials
Canoga Park, California 91306
33
mi
from 91732
Canoga Park, CA
Click here to add this to my saved trials
811
mi
from 91732
Denver, CO
Click here to add this to my saved trials
340 W 10th St #6200
Indianapolis, Indiana 46202
(317) 274-3772
Principal Investigator: Kenneth Fife, MD
Phone: 317-274-8115
Indiana University School of Medicine With more than 2,000 students in 2013, the Indiana University...
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
884 Lakeland Drive
Jackson, Mississippi 39216
Principal Investigator: Leandro Mena, MD
Phone: 601-984-5560
1609
mi
from 91732
Jackson, MS
Click here to add this to my saved trials
Los Angeles, California 90069
Principal Investigator: Anthony Mills, MD
Phone: 310-550-2271
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Maryville, Tennessee 37804
1922
mi
from 91732
Maryville, TN
Click here to add this to my saved trials
New Haven, Connecticut 06520
Principal Investigator: Michael Kozal, MD
Phone: 203-737-4040
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
New Orleans, Louisiana 70112
Principal Investigator: Stephanie N Taylor, MD
Phone: 504-568-4132
1655
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
10040 Regency Cir
Omaha, Nebraska 68114
(402) 934-0044
Principal Investigator: Michael Dunn, MD
Phone: 402-934-0044
Quality Clinical Research, Inc. Welcome to Quality Clinical Research. We originated here in Omaha, NE...
1295
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Philadephia, Pennsylvania 19107
Principal Investigator: Joel Lebed, DO
Phone: 267-514-2098
2375
mi
from 91732
Philadephia, PA
Click here to add this to my saved trials
Phoenix, Arizona 85018
348
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Portland, Oregon 97210
827
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Rochester, New York 14609
2245
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Salt Lake City, Utah 84108
577
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Shreveport, Louisiana 71103
Principal Investigator: John Vanchiere, MD, PhD
Phone: 318-675-6081
1401
mi
from 91732
Shreveport, LA
Click here to add this to my saved trials
Towson, Maryland 21204
2301
mi
from 91732
Towson, MD
Click here to add this to my saved trials
Webster, Texas 77598
Principal Investigator: Stephen Tyring, MD
Phone: 281-333-2288
1377
mi
from 91732
Webster, TX
Click here to add this to my saved trials